Tibotec

Tibotec was a pharmaceutical company with a focus on research and development for the treatment of infectious diseases such as HIV/AIDS and hepatitis C. The company was founded in 1994 and then acquired by Johnson & Johnson and merged into its Janssen Pharmaceuticals division in 2002.

Tibotec
IndustryPharmaceutical
Founded1994 (1994)
Founders
  • Rudi Pauwels
  • Carine Claeys
  • Marie-Pierre de Béthune
  • Kurt Hertogs
  • Hilde Azijn
Defunct2002 (2002)
FateAcquired by Johnson & Johnson and merged into its Janssen Pharmaceuticals division
Websitetibotec.com

The name of the company is derived from the tetrahydro-imidazo[4,5,1-jk][1,4]-benzodiazepine-2(1H)-one and -thione (TIBO) compounds discovered at the Rega Institute for Medical Research (Belgium).

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.